☆ 4.7 Review

Medicinal products meet medical devices: Classification and nomenclature issues arising from their combined use

DRUG DISCOVERY TODAY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Engineering, Biomedical

Regulatory perspectives of combination products

Jiaxin Tian et al.

Summary: Combination products, composed of multiple medical devices or drugs/biological products, present unique challenges in research, translation, and regulatory evaluation. New tools and approaches have been developed to assess the safety, efficacy, quality, and performance of combination products, offering opportunities for advancements in regulatory review and science.

BIOACTIVE MATERIALS (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Considerations on D-mannose Mechanism of Action and Consequent Classification of Marketed Healthcare Products

Francesco Scaglione et al.

Summary: Urinary tract infections (UTIs) are common disorders that affect adult women, often caused by uropathogenic Escherichia coli. Recurrent UTIs are frequently treated with non-prescribed antibiotics by patients, leading to increased antibiotic resistance issues. D-mannose has been proposed as an alternative approach for managing UTIs due to its ability to inhibit bacterial adhesion to the urothelium.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Biomarker and Companion Diagnostics-A Review of Medicinal Products Approved by the European Medicines Agency

Laura Patricia Orellana Garcia et al.

Summary: The study analyzed the information and recommendations related to biomarker testing, including CDx, in SmPCs and EPARs of EU medicinal products approved via the centralised procedure at EMA. The results showed varied levels of detail and presentation of information on biomarkers and diagnostic tests in the documents. Overall, there was transparent but sometimes heterogeneous reporting of CDx in the SmPC and EPAR.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Companion Diagnostics: State of the Art and New Regulations

Vasiliki Valla et al.

Summary: Companion diagnostics show potential for improving drug development and precision medicine, but face challenges in clinical development and regulation. The European Union is implementing new regulations for in vitro diagnostic medical devices, which will have an impact on all stakeholders in the IVD industry.

BIOMARKER INSIGHTS (2021)

添加到收藏夹

Article Health Care Sciences & Services

Characterization of Device-Related Malfunction, Injury, and Death Associated with Using Elastomeric Pumps for Delivery of Local Anesthetics in the US Food and Drug Administration MAUDE Database

Richard Teames et al.

DRUG HEALTHCARE AND PATIENT SAFETY (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Glatiramer acetate: A complex drug beyond biologics

Paolo Rocco et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) database

Oluwadolapo D. Lawal et al.

EXPERT OPINION ON DRUG SAFETY (2018)

添加到收藏夹

Editorial Material Biotechnology & Applied Microbiology

Combination products: modernizing the regulatory paradigm

Nina L. Hunter et al.

NATURE REVIEWS DRUG DISCOVERY (2017)

添加到收藏夹

Review Pharmacology & Pharmacy

Is the European regulatory framework sufficient to assure the safety of citizens using health products containing nanomaterials?

Umberto M. Musazzi et al.

DRUG DISCOVERY TODAY (2017)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Development of Companion Diagnostics

David A. Mankoff et al.

SEMINARS IN NUCLEAR MEDICINE (2016)

添加到收藏夹

Article Cell & Tissue Engineering

A 3D bioprinting exemplar of the consequences of the regulatory requirements on customized processes

Paul Hourd et al.

REGENERATIVE MEDICINE (2015)

添加到收藏夹

Review Pharmacology & Pharmacy

Low molecular weight heparins copies: are they considered to be generics or biosimilars?

Paola Minghetti et al.

DRUG DISCOVERY TODAY (2013)

添加到收藏夹

Review Pharmacology & Pharmacy

Lessons from innovation in drug-device combination products

Daniela S. Couto et al.

ADVANCED DRUG DELIVERY REVIEWS (2012)

添加到收藏夹

Editorial Material Pharmacology & Pharmacy

Combination Products Regulation at the FDA

K. J. Lauritsen et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)

添加到收藏夹

Article Primary Health Care

Severe Deterioration of Metabolic Control Caused by Malfunction of a Disposable Insulin Pen Device

Mauro Boronat et al.

JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.